Daily BriefsJapan

Daily Brief Japan: Cosmo Energy Holdings , Japan Tobacco, Appier Group, TSE Tokyo Price Index TOPIX and more

In today’s briefing:

  • Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill
  • Japan Tobacco High Conviction Call: Could Leave 2023 Guidance in the Dust
  • Appier (4180) | The Ups and Downs
  • % of Female Board Members Is a Measure of a Company’s Seriousness About Improving Its Practices


Cosmo Energy (5021) – Headed to an EGM Showdown for the Poison Pill

By Travis Lundy

  • Japanese activist Murakami-san and Cosmo Energy Holdings (5021 JP) have been duking it out for 18 months. He now has 20%. Wants more. Management wants to exercise the poison pill. 
  • Cosmo’s efforts are not completely honest, but Murakami-san’s efforts are clearly designed to benefit Murakami-san over general shareholders, and Cosmo has finally explained the reasons publicly. Read the doc (Japanese).
  • At 1.0x book, lower refining margins vs earlier in the year, and difficulty for Murakami-san to force the issue, one must take more care here than one did 40% ago.

Japan Tobacco High Conviction Call: Could Leave 2023 Guidance in the Dust

By Oshadhi Kumarasiri

  • Despite conservative 2023 guidance last quarter, Japan Tobacco (2914 JP) is primed to exceed expectations in the 3rd quarter of 2023.
  • Despite no new domestic price hikes, Japan Tobacco’s volume recovery post-hikes is expected to help sustain the revenue and profit growth momentum.
  • New price increases in the Philippines and the UK, coupled with last year’s hikes spillover, are expected to boost Japan Tobacco’s earnings; and the yen’s depreciation amplifies these gains.

Appier (4180) | The Ups and Downs

By Mark Chadwick

  • Appier’s stock initially surged 20% following strong Q2 results but later declined 25%, influenced by small-cap stock volatility, AI-induced valuations, and e-commerce sensitivity.
  • The AI company’s competitive position remains strong compared to Braze; the differing stock price performance and valuation suggests significant upside.
  • Appier’s thesis remains intact and we expect the company to benefit from key trends in consumer marketing, first-party data and AI solutions.

% of Female Board Members Is a Measure of a Company’s Seriousness About Improving Its Practices

By Aki Matsumoto

  • The groups with over 30% female board members and 25%-30% have higher percentage of foreign shareholders, suggesting that overseas investor engagement drives raising the ratio and that awareness is high.
  • Groups with 0% female board members include small companies and are distant from overseas investor engagement, but are unlikely to improve practices substantially, given that they have no female executives.
  • The group with over 30% female board members had noticeably higher ROE and Tobin’sQ than those with 25%-30%, which suggests that the high ROE was highly valued by overseas investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars